Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article
Open Access

Raising an Antibody Specific to Breast Cancer Subpopulations Using Phage Display on Tissue Sections

SIMON ASBJØRN LARSEN, THERESA MELDGAARD, AGLA JAEL RUBNER FRIDRIKSDOTTIR, SIMON LYKKEMARK, PI CAMILLA POULSEN, LAURA FALKENSTEEN OVERGAARD, HELENE BUNDGAARD PETERSEN, OLE WILLIAM PETERSEN and PETER KRISTENSEN
Cancer Genomics & Proteomics January 2016, 13 (1) 21-30;
SIMON ASBJØRN LARSEN
1Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THERESA MELDGAARD
2Department of Engineering, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AGLA JAEL RUBNER FRIDRIKSDOTTIR
3Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMON LYKKEMARK
4Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
5Sino-Danish Centre for Education and Research (SDC), Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PI CAMILLA POULSEN
2Department of Engineering, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAURA FALKENSTEEN OVERGAARD
2Department of Engineering, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HELENE BUNDGAARD PETERSEN
2Department of Engineering, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLE WILLIAM PETERSEN
3Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER KRISTENSEN
2Department of Engineering, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pk{at}eng.au.dk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Illustration of the antibody fragment selection procedure and screening strategies. The target area for selection was chosen to be the middle part of a particular cancer nest due to clustered CD271+ staining present. The entire tissue on a consecutive formalin-fixed section was then incubated with a phage library. The target area was relocated and a minute disc (shadow stick) was positioned precisely above the target cells of interest. The target area was kept moist at all times. The shadow stick shielded the phage antibodies binding to cells of interest from UV-C irradiation. The phages were eluted, but only those protected by the shadow stick can replicate in bacteria and provide ampicillin resistance. Each colony represented an antibody fragment, which required screening for their specificity. They were picked and grown in separate wells of a master plate. 1) In the initial screening, all colonies were grown in microtiter plates and monoclonal phage antibodies produced. The phage antibodies were tested by phage ELISA on CD271+ cancer cells. 2) All phage antibodies bound with higher affinities than the negative control in the initial screening were produced monoclonally in 50-ml cultures. These were tested in different concentrations by a phage ELISA titration assay, which was performed simultaneously on CD271+ cancer cells and CD271+myoepithelial cells. This provided comparative results of each phage antibody. 3) Soluble antibody fragments were expressed and purified, and examined by IHC experiments on four different breast cancer biopsies to validate their specificity.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Immunohistochemistry showing breast cancer-specific staining with an antibody against fragment LH8. Immunohistochemistry was performed on three seperate sections of cryostat tissue from the luminal breast cancer patient 761. All pictures are merged with DAPI staining. Pictures A, C and E show staining against CK19, which indicate the presence of cancer cells. Picture B shows staining with the antibody fragment LH8 which consistently only binds cancer cells. The presence of cancer cells is confirmed by staining with the proliferation marker ki67 within these areas, as observed in picture D. Picture F shows staining with the mouse Cy3 conjugated anti-c-Myc antibody used for detection of the antibody fragments. This shows that the observed staining is not caused by up-regulated c-myc expression in cancer cells or unspecific binding by this secondary antibody.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Immunohistochemistry showing differential staining intensity in patient 761. The figure shows two different areas on the same section of a cryostat tissue from the luminal breast cancer patient 761. All pictures are merged with DAPI staining. Pictures A and C show staining against CK19. Picture B and D shows staining with the antibody fragment LH8. Although the pictures are from the same tissue section there exist variations in the staining pattern. Cancer cells are not uniformly stained but rather display different areas with different intensity. Some areas of cancer cells present very limited staining (Figure D, upper left and right) whereas others are very intense.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Immunohistochemistry showing differential staining intensity in patient 686. The figure shows two different areas on cryostat tissue from luminal breast cancer of patient 686 at higher magnification. All pictures are merged with DAPI staining. Pictures A and C show staining against CK19. Pictures B and D show staining with LH8. The pictures are representative and display an obvious difference in staining intensity in different cancer areas.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Immunohistochemistry performed on healthy breast tissue. For further characterization of LH8, immunohistochemistry was performed on tissue sections from three healthy donors. Picture A, D and G show DAPI staining. B, E and H show staining against CK19. Picture C, F and I show staining with the antibody fragment LH8. The upper, middle and lower rows represent the healthy donors P671, P820 and P923 respectively. No staining was observed in neither the healthy luminal cells or stroma.

PreviousNext
Back to top

In this issue

Cancer Genomics & Proteomics
Vol. 13, Issue 1
January-February 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Raising an Antibody Specific to Breast Cancer Subpopulations Using Phage Display on Tissue Sections
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Raising an Antibody Specific to Breast Cancer Subpopulations Using Phage Display on Tissue Sections
SIMON ASBJØRN LARSEN, THERESA MELDGAARD, AGLA JAEL RUBNER FRIDRIKSDOTTIR, SIMON LYKKEMARK, PI CAMILLA POULSEN, LAURA FALKENSTEEN OVERGAARD, HELENE BUNDGAARD PETERSEN, OLE WILLIAM PETERSEN, PETER KRISTENSEN
Cancer Genomics & Proteomics Jan 2016, 13 (1) 21-30;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Raising an Antibody Specific to Breast Cancer Subpopulations Using Phage Display on Tissue Sections
SIMON ASBJØRN LARSEN, THERESA MELDGAARD, AGLA JAEL RUBNER FRIDRIKSDOTTIR, SIMON LYKKEMARK, PI CAMILLA POULSEN, LAURA FALKENSTEEN OVERGAARD, HELENE BUNDGAARD PETERSEN, OLE WILLIAM PETERSEN, PETER KRISTENSEN
Cancer Genomics & Proteomics Jan 2016, 13 (1) 21-30;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Establishment of a Patient-derived Xenograft for Development of Personalized HER2-targeting Therapy in Gastric Cancer
  • Google Scholar

Keywords

  • Phage display
  • biomarkers
  • Breast cancer
  • tissue
  • CD271+
  • shadow stick
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire